This country profile provides an overview of Madagascar’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 58/100
Overall rank: Joint 11th

Treatment coverage

Lymphatic filariasis
44%
Onchocerciasis
N/A
Schistosomiasis
48%
STH
92%
Trachoma
N/A
8.7 million people received treatment in Madagascar in 2016 10.1 million people in need did not receive treatment in Madagascar in 2016

Madagascar recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

⬇️ Treatment coverage decreased from 47% in 2015 to 44% in 2016.

People needing treatment
18.9m
People receiving treatment
8.3m

Onchocerciasis

Madagascar does not require mass treatment for onchocerciasis.

Schistosomiasis

⬆️ Treatment coverage increased from 44% in 2015 to 48% in 2016.

School-aged children needing treatment
3.5m
School-aged children receiving treatment
1.49m

Soil-transmitted helminths

⬆️ Treatment coverage increased from 75% in 2015 to 92% in 2016.

Pre-sch and school-aged children needing treatment
4.39m
Pre-school and school-aged children receiving treatment
4.04m

Trachoma

Madagascar does not require mass treatment for trachoma.